Grants and Contributions:
Title:
Entering European Markets with Spartan’s Medical Platform: rapid CYP2C19 testing and portable COVID19 testing
Agreement Number:
953830
Agreement Value:
$75,000.00
Agreement Date:
Jul 1, 2020 - Feb 28, 2021
Description:
To commercialize Spartan’s medical platform. We are commercializing the CYP2C19 test upon the success of the European landmark POPular Genetics clinical trial and the COVID19 test to fight the global pandemic.
Organization:
National Research Council Canada
Expected Results:
CanExport SMEs is designed to provide direct financial assistance to small- and medium-sized enterprises seeking to develop new export market opportunities and markets, especially in high-growth emerging markets.
Location:
Ottawa, Ontario, CA k2h 1b2
Reference Number:
172-2020-2021-Q2-953830
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
855952438
Recipient Type:
For-profit organization
Recipient's Legal Name:
Spartan Bioscience Inc
Federal Riding Name:
Ottawa West--Nepean
Federal Riding Number:
35079
Program:
CanExport SMEs
Program Purpose:
CanExport SMEs is designed to provide direct financial assistance to small- and medium-sized enterprises seeking to develop new export market opportunities and markets, especially in high-growth emerging markets.
Coverage:
CanExport SMEs projects lead to increased export diversification and growth for Canadian small and medium enterprises.
NAICS Code:
334512